Total Cytotoxic NK cells (CD16+)

Elevated levels of Total Cytotoxic NK cells (CD16+) can indicate an active immune response against infections, tumors, or other pathological conditions, reflecting the body's attempt to combat these challenges. Such an increase often suggests an ongoing battle against viral infections or the presence of malignant cells, as NK cells play a crucial role in identifying and destroying compromised cells without prior sensitization. Additionally, persistently high levels may signal an underlying autoimmune disorder or a chronic inflammatory state, where the immune system is in a heightened state of alert, potentially targeting the body's own tissues mistakenly. The interpretation of these elevated levels, particularly within the context of the Lymphocyte MAP panel from Cyrex Laboratories, requires a comprehensive assessment by healthcare professionals, taking into account the patient's clinical history, symptoms, and other diagnostic findings to understand the implications fully and tailor appropriate therapeutic interventions.

Total Cytotoxic NK (Natural Killer) cells, identified by the CD16+ marker, represent a crucial component in the innate immune system, playing a significant role in the body's first line of defense against tumors and virally infected cells.

NK cells, characterized by their expression of the CD16 surface marker, are involved in the direct killing of target cells without the need for prior sensitization, distinguishing them from other lymphocytes that require antigen presentation. They are pivotal in controlling early responses to infection and malignancy through the release of cytolytic granules that induce apoptosis in target cells.